• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

具有不同拓扑异构酶 II 抑制和细胞毒性谱的刺五加吡喃并萘醌衍生物、通气醌 L、硫酮和那那霉素 A。

Pyranonaphthoquinone derivatives of eleutherin, ventiloquinone L, thysanone and nanaomycin A possessing a diverse topoisomerase II inhibition and cytotoxicity spectrum.

机构信息

Department of Chemistry, University of Auckland, 23 Symonds Street, Auckland, New Zealand.

出版信息

Bioorg Med Chem. 2009 Oct 15;17(20):7131-7. doi: 10.1016/j.bmc.2009.08.064. Epub 2009 Sep 4.

DOI:10.1016/j.bmc.2009.08.064
PMID:19783445
Abstract

A series of pyranonaphthoquinone derivatives related to the known topoisomerase II inhibitor eleutherin 1 have been shown to act as specific topoisomerase II catalytic inhibitors, with several analogues displaying greater potency than the natural product itself. Amongst the compounds tested were the natural products ventiloquinone L 4 and thysanone 8 with a diverse range of topoisomerase II inhibition properties being observed. Interestingly, the natural products are generally weaker inhibitors than their synthetic counterparts, emphasising that subtle changes in the basic molecular structure of a natural product led to significant changes in the inhibition profile. It has also been demonstrated for the first time that analogues related to nanaomycin A and cardinalin-type dimeric pyranonaphthoquinones exhibit potent topoisomerase II inhibitory properties. With respect to structural features, it appears that the nature of the substituents at C1 on the pyran ring and oxygenated substituents on the aryl ring are critical for anti-topoII activity. Importantly, the topoisomerase II inhibition strength does not correlate well with the measured cytotoxicity against yeast, indicating that other molecular features in the pyranonaphthoquinone family must be considered for the design and use of this structural class as highly specific topoisomerase II inhibitors.

摘要

已证明一系列与已知拓扑异构酶 II 抑制剂 eleutherin 1 相关的吡喃并萘醌衍生物可作为特定的拓扑异构酶 II 催化抑制剂,其中几种类似物的活性比天然产物本身更强。在测试的化合物中,有天然产物 ventiloquinone L 4 和 thysanone 8,它们表现出多种拓扑异构酶 II 抑制特性。有趣的是,天然产物通常比其合成对应物弱抑制剂,这强调了天然产物基本分子结构的细微变化会导致抑制谱的显著变化。这也是首次证明与 nanaomycin A 和 cardinalin 型二聚吡喃并萘醌相关的类似物具有很强的拓扑异构酶 II 抑制特性。就结构特征而言,似乎吡喃环上 C1 位的取代基的性质和芳基环上的含氧取代基对于抗拓扑异构酶 II 活性至关重要。重要的是,拓扑异构酶 II 抑制强度与对酵母的测量细胞毒性相关性不好,这表明在设计和使用这种结构类别作为高度特异性拓扑异构酶 II 抑制剂时,必须考虑吡喃并萘醌家族中的其他分子特征。

相似文献

1
Pyranonaphthoquinone derivatives of eleutherin, ventiloquinone L, thysanone and nanaomycin A possessing a diverse topoisomerase II inhibition and cytotoxicity spectrum.具有不同拓扑异构酶 II 抑制和细胞毒性谱的刺五加吡喃并萘醌衍生物、通气醌 L、硫酮和那那霉素 A。
Bioorg Med Chem. 2009 Oct 15;17(20):7131-7. doi: 10.1016/j.bmc.2009.08.064. Epub 2009 Sep 4.
2
Novel mechanisms of DNA topoisomerase II inhibition by pyranonaphthoquinone derivatives-eleutherin, alpha lapachone, and beta lapachone.吡喃萘醌衍生物(榄香烯、α-拉帕醌和β-拉帕醌)抑制DNA拓扑异构酶II的新机制。
Biochem Pharmacol. 2000 Nov 1;60(9):1367-79. doi: 10.1016/s0006-2952(00)00437-8.
3
Naphthazarin derivatives (II): formation of glutathione conjugate, inhibition of DNA topoisomerase-I and cytotoxicity.萘茜衍生物(II):谷胱甘肽缀合物的形成、DNA拓扑异构酶-I的抑制作用及细胞毒性
Bioorg Med Chem Lett. 1999 Aug 16;9(16):2407-12. doi: 10.1016/s0960-894x(99)00397-2.
4
Novel mechanism of cellular DNA topoisomerase II inhibition by the pyranonaphthoquinone derivatives alpha-lapachone and beta-lapachone.
Cancer Chemother Pharmacol. 2001 Mar;47(3):187-98. doi: 10.1007/s002800000221.
5
Synthesis of 2-(thienyl-2-yl or -3-yl)-4-furyl-6-aryl pyridine derivatives and evaluation of their topoisomerase I and II inhibitory activity, cytotoxicity, and structure-activity relationship.合成 2-(噻吩-2-基或-3-基)-4-呋喃基-6-芳基吡啶衍生物,并评价其拓扑异构酶 I 和 II 抑制活性、细胞毒性以及构效关系。
Bioorg Med Chem. 2010 Mar 15;18(6):2245-2254. doi: 10.1016/j.bmc.2010.01.065. Epub 2010 Feb 4.
6
Coralyne and related compounds as mammalian topoisomerase I and topoisomerase II poisons.珊瑚灵及相关化合物作为哺乳动物拓扑异构酶I和拓扑异构酶II的抑制剂
Bioorg Med Chem. 1996 Jun;4(6):781-91. doi: 10.1016/0968-0896(96)00054-5.
7
New insight for fluoroquinophenoxazine derivatives as possibly new potent topoisomerase I inhibitor.氟喹诺吩嗪衍生物作为可能的新型强效拓扑异构酶I抑制剂的新见解。
Bioorg Med Chem Lett. 2008 Feb 15;18(4):1520-4. doi: 10.1016/j.bmcl.2007.12.053. Epub 2007 Dec 25.
8
Cytotoxicity and DNA topoisomerase inhibitory activity of benz[f]indole-4,9-dione analogs.苯并[f]吲哚-4,9-二酮类似物的细胞毒性和DNA拓扑异构酶抑制活性
Biosci Biotechnol Biochem. 2003 Sep;67(9):1944-9. doi: 10.1271/bbb.67.1944.
9
Design, synthesis and biological evaluation of novel mansonone E derivatives prepared via CuAAC click chemistry as topoisomerase II inhibitors.通过铜AAC 点击化学设计、合成及新型曼森酮 E 衍生物的生物评价作为拓扑异构酶 II 抑制剂。
Eur J Med Chem. 2013 Oct;68:58-71. doi: 10.1016/j.ejmech.2013.07.011. Epub 2013 Aug 1.
10
Design, synthesis and biological evaluation of lapachol derivatives possessing indole scaffolds as topoisomerase I inhibitors.具有吲哚骨架的拉帕醇衍生物作为拓扑异构酶I抑制剂的设计、合成及生物学评价
Bioorg Med Chem. 2016 Nov 15;24(22):5781-5786. doi: 10.1016/j.bmc.2016.09.034. Epub 2016 Sep 15.

引用本文的文献

1
Benzochromenopyrimidines: Synthesis, Antiproliferative Activity against Colorectal Cancer and Physicochemical Properties.苯并色烯并嘧啶类化合物的合成、抗结直肠癌细胞增殖活性及理化性质。
Molecules. 2022 Nov 15;27(22):7878. doi: 10.3390/molecules27227878.
2
Induction of apoptosis by Xiakemycin A in human hepatoma HepG2 cells.
Medicine (Baltimore). 2020 Apr;99(17):e19848. doi: 10.1097/MD.0000000000019848.
3
Secondary metabolites from hypocrealean entomopathogenic fungi: novel bioactive compounds.虫生拟青霉属真菌中的次生代谢产物:新型生物活性化合物。
Nat Prod Rep. 2020 Sep 23;37(9):1181-1206. doi: 10.1039/c9np00065h.
4
Discovery of indeno[1, 2 - c] quinoline derivatives as dual topoisomerases I/II inhibitors: part 3.吲哚并[1,2-c]喹啉衍生物作为拓扑异构酶 I/II 双重抑制剂的发现:第 3 部分。
Mol Divers. 2013 Nov;17(4):781-799. doi: 10.1007/s11030-013-9475-5.